Categories
Stocks News Business News Global News Market News Earnings News IPO News
Quick Links
Ongoing IPO's Upcoming IPO's Closed IPO's Research Call's

novo nordisk

  1. H

    India’s Generic Semaglutide Market Faces Branding Dispute

    Dr. Reddy’s to Rename Semaglutide Drug Following Court Concerns Brand Name Change Underway New Delhi – Dr. Reddy’s Laboratories informed the Delhi High Court on Friday that it intends to change the brand name of its semaglutide drug from ‘Olymviq’ to ‘Olymra’. This decision follows a judge’s...
    • Himanshu
    • Thread
    • brand name change diabetes dr. reddy's laboratories drug approval generic drugs glp-1 receptor agonist india legal dispute novo nordisk olymra olymviq ozempic pharmaceuticals semaglutide type 2 diabetes
    • Replies: 0
    • Forum: Business
  2. K

    Weight Loss Drug Collaboration: Novo Nordisk and Hims

    Novo Nordisk Drops Lawsuit Against Hims & Hers After Agreement to Sell Wegovy and Ozempic Through Platform Novo Nordisk has dropped its lawsuit against telehealth company Hims & Hers after both firms reached an agreement that will allow the pharmaceutical company’s branded weight loss...
    • Karthik
    • Thread
    • drug advertising drug development fda regulations glp-1 drugs hims & hers injectable wegovy legal dispute novo nordisk oral wegovy ozempic pharmaceutical companies semaglutide telehealth wegovy weight loss medication
    • Replies: 0
    • Forum: Business
Back
Top